Legend Biotech (LEGN) Operating Expenses (2019 - 2025)
Historic Operating Expenses for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$147.9 million.
- Legend Biotech's Operating Expenses fell 1303.07% to -$147.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$412.3 million, marking a year-over-year decrease of 11.22%. This contributed to the annual value of -$550327.0 for FY2024, which is 1254.43% down from last year.
- As of Q3 2025, Legend Biotech's Operating Expenses stood at -$147.9 million, which was down 1303.07% from -$130.9 million recorded in Q2 2025.
- Legend Biotech's Operating Expenses' 5-year high stood at -$79836.0 during Q1 2021, with a 5-year trough of -$148.0 million in Q2 2024.
- Over the past 5 years, Legend Biotech's median Operating Expenses value was -$107.4 million (recorded in 2022), while the average stood at -$98.7 million.
- Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 11789814.62% in 2022, then surged by 9987.49% in 2023.
- Quarter analysis of 5 years shows Legend Biotech's Operating Expenses stood at -$103.6 million in 2021, then decreased by 3.66% to -$107.4 million in 2022, then skyrocketed by 99.87% to -$134390.0 in 2023, then fell by 3.16% to -$138633.0 in 2024, then plummeted by 106562.19% to -$147.9 million in 2025.
- Its Operating Expenses stands at -$147.9 million for Q3 2025, versus -$130.9 million for Q2 2025 and -$133.4 million for Q1 2025.